Ads
related to: mood disorder- FAQs
Get Answers to Commonly Asked
Questions About Depression.
- Download The Brochure
Learn More About This Treatment
Download The Patient Brochure
- Helpful Videos
Watch Patient's Journey With
Depression & This Treatment
- Still Depressed On Rx?
Your Antidepressant May Only Be
Partially Working. Learn More.
- Patient Tools & Resources
Get Helpful Tools
And Resources.
- Doctor Conversation Guide
Ready To Talk To Your Doctor About
Your Symptoms? Download The Guide
- FAQs
Search results
Federal judge denies new psychiatric exam of Quintez Brown
WDRB 41 Louisville News· 5 days agoA judge Wednesday declined to order a new psychiatric examination of Quintez Brown, who faces...
One in two children with ADHD experience emotional problems, study finds
Medical Xpress· 6 days agoIn research published in Nature Mental Health, the team found that as many as one in two children with ADHD show signs of emotional dysregulation, and that Ritalin—the commonly-prescribed drug ...
Helping Primary Care Teams Provide Culturally Appropriate Care for Diverse Patients
Psychiatric Times· 4 days ago“Brandon” is a 42-year-old African American man with acquired hearing loss who lost his job due to layoffs during the COVID-19 pandemic. Although this is during the early stages of the pandemic ...
Dynamic Technology Lab Private Ltd Reduces Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoDynamic Technology Lab Private Ltd decreased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 59.3% during the 4th quarter, according to the company in its most recent ...
McGinn Penninger Investment Management Inc. Sells 365 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoMcGinn Penninger Investment Management Inc. decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.8% in the 4th quarter, according to its most recent Form 13F filing ...
Johnson & Johnson (NYSE:JNJ) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 7 days agoBI Asset Management Fondsmaeglerselskab A S lifted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 59.0% in the 4th quarter, according to the company in its most recent 13F filing ...
Neurocrine Biosciences Announces Publication of Phase 3 KINECT®-4 Post Hoc Analysis Demonstrating...
FOX 59 Indianapolis· 7 days agoNeurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the publication of data from a post hoc analysis of the Phase 3 KINECT®-4 study of INGREZZA® (valbenazine) capsules in the Journal ...
Norges Bank Purchases New Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoJohnson & Johnson comprises 0.7% of Norges Bank’s investment portfolio, making the stock its 18th largest position. Other hedge funds and other institutional investors also recently modified ...
Johnson & Johnson (NYSE:JNJ) Trading Down 1.1%
ETF DAILY NEWS· 3 days agoShares of Johnson & Johnson (NYSE:JNJ – Get Free Report) were down 1.1% during mid-day trading on Thursday . The company traded as low as $151.70 and last traded at $151.81. Approximately 1,428,737 ...
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed by Royal Bank of Canada
ETF DAILY NEWS· 4 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Royal Bank of Canada in a report issued on Wednesday, Benzinga reports.
Ad
related to: mood disorder